Yan-Ping Mao

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Ying Sun, Wen-Fei Li, Nian-Yong Chen et al. · The Lancet Oncology · 2016 · 950 citations

Medicine, Oncology, Radiation Oncology +14

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

Lei Chen, Chaosu Hu, Xiao-Zhong Chen et al. · The Lancet Oncology · 2011 · 564 citations

Medicine, Oncology, Radiation Oncology +14

Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study

Xin-Ran Tang, Ying-Qin Li, Shao-Bo Liang et al. · The Lancet Oncology · 2018 · 310 citations

Medicine, Bioinformatics, Oncology +17

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Xu Liu, Yuan Zhang, Kun-Yu Yang et al. · The Lancet · 2024 · 170 citations

Medicine, Oncology, Radiation Oncology +15